# Hikal Ltd (HIKAL)
> Exchange: NSE | Sector: Pharma | ISIN: INE475B01022

## About
Hikal Ltd is a Pharma company listed on NSE.
Sector: Pharma

## Returns
1Y Return: 11.1%

## Profitability
ROE: 2.2%

## Access
Current tier: anonymous
More history: Register free to see 10 more years.

## Data Freshness
Quote Updated: 2026-09-08T08:01:00.000Z
Price History Updated: 2026-09-08T18:56:33.252Z
Latest Price History Date: 2026-09-08
Technicals Updated: 2026-09-08T18:56:33.252Z
Quant Updated: 2026-09-08T18:56:33.252Z
Sentiment Updated: 2026-09-08T18:56:33.252Z
Financials Status: current
Financials Updated: 2026-09-10T03:34:27.150Z
Financials Last Attempt: 2026-09-10T03:34:27.150Z
Financials Provider Tried: screener.in+yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (TTM)
Revenue: ₹1735 Cr
Operating Profit: ₹232 Cr (OPM 13%)
Net Profit: ₹-34 Cr
Tax: ₹-24 Cr

## Annual P&L History
TTM: Rev ₹1735Cr | PAT ₹-34Cr | OPM 13%
FY26: Rev ₹1713Cr | PAT ₹-49Cr | OPM 13%
FY25: Rev ₹1860Cr | PAT ₹91Cr | OPM 18%

## Balance Sheet (FY26)
Total Assets: ₹2365 Cr
Total Liabilities: ₹2365 Cr
Borrowings: ₹684 Cr
Cash: —

## Shareholding
Promoters: 68.85%
FIIs: 0.98%
DIIs: 7.23%
Public: 22.92%

---
Source: rupiya.io/stocks/hikal
Disclaimer: For research and education only. Not investment advice.